Predicting survival of cancer patients by chromosomal copy number heterogeneity

Research output: Contribution to journalArticle*Academicpeer-review

Abstract

We recently introduced a method to derive intra-tumor heterogeneity (ITH) from a single copy number measurement. This method stratifies patients for survival and could potentially help to identify low and high-risk patients with clinical relevance.
Original languageEnglish
Article number1949956
JournalMolecular & cellular oncology
Early online date2021
DOIs
Publication statusE-pub ahead of print - 2021

Keywords

  • Biomarker
  • chromosomal instability
  • intra-tumor heterogeneity
  • pan-cancer

Cite this